Evidence map›Paper›PMID 33085679›Full record

ArticlePloS one2020

Humoral responses to the measles, mumps and rubella vaccine are impaired in Leigh Syndrome French Canadian patients.

Adrien Fois, Anne-Marie Boucher-Lafleur, Julie Thompson Legault, Christian Renaud, Charles Morin, Christine Des Rosiers, Lise Coderre, Catherine Laprise, Sylvie Lesage, LSFC Consortium

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Disruption ofJournal of rare diseases (Berlin, Germany) · 2025
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Adrien FoisImmunology-oncology Section, Maisonneuve-Rosemont Hospital Research Center, Montréal, Québec, Canada.
Anne-Marie Boucher-LafleurCentre intersectoriel en santé durable, Université du Québec à Chicoutimi, Saguenay, Québec, Canada.
Julie Thompson LegaultResearch Center, Montreal Heart Institute, Montréal, Québec, Canada.
Christian RenaudDépartement de microbiologie, infectiologie et immunologie, Université de Montréal, Montréal, Québec, Canada.
Charles MorinHôpital de Chicoutimi, Chicoutimi, Québec, Canada.
Christine Des RosiersResearch Center, Montreal Heart Institute, Montréal, Québec, Canada.
Lise CoderreImmunology-oncology Section, Maisonneuve-Rosemont Hospital Research Center, Montréal, Québec, Canada.
Catherine LapriseCentre intersectoriel en santé durable, Université du Québec à Chicoutimi, Saguenay, Québec, Canada.
Sylvie LesageImmunology-oncology Section, Maisonneuve-Rosemont Hospital Research Center, Montréal, Québec, Canada.ORCID 0000-0002-0968-2795
LSFC Consortium
Hôpital Maisonneuve-Rosemont · CAMontreal Heart Institute · CAUniversité du Québec à Chicoutimi · CAUniversité de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leigh Syndrome French Canadian (LSFC) is a rare autosomal recessive metabolic disorder characterized by severe lactic acidosis crises and early mortality. LSFC patients carry mutations in the Leucine Rich Pentatricopeptide Repeat Containing (LRPPRC) gene, which lead to defects in the respiratory chain complexes and mitochondrial dysfunction. Mitochondrial respiration modulates cellular metabolic activity, which impacts many cell types including the differentiation and function of immune cells. Hence, we postulated that, in addition to neurological and metabolic disorders, LSFC patients may show impaired immune activity. To gain insight into the quality of the immune response in LSFC patients, we examined the response to the measles, mumps and rubella (MMR) vaccine by measuring antibody titers to MMR in the plasma. In a cohort of eight LSFC patients, the response to the MMR vaccine was variable, with some individuals showing antibodies to all three viruses, while others had antibodies to two or fewer viruses. These results suggest that the mutations in the LRPPRC gene present in LSFC patients may affect the immune response to vaccines. Monitoring vaccine response in this fragile population should be considered to ensure full protection against pathogens.

Indexed as

Immunogenicity, VaccineAdolescentAdultAntibodies, ViralChildFemaleHumansLeigh DiseaseMaleMeasles-Mumps-Rubella VaccineNeoplasm ProteinsQuebecVaccinationAntibodies, ViralLRPPRC protein, humanMeasles-Mumps-Rubella VaccineNeoplasm Proteins

Identifiers

PMID33085679
PMCPMC7577467
OpenAlexW3094262672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.